Nonalcoholic fatty liver disease promotes hepatocellular carcinoma through direct and indirect effects on hepatocytes
Hepatocellular carcinoma (HCC) is the sixth most frequent neoplasm and the second leading cause of cancer‐related deaths worldwide. Nonalcoholic fatty liver disease (NAFLD), a common disorder in obese people, has been identified as an important risk factor for HCC. Following the increasing prevalenc...
Gespeichert in:
Veröffentlicht in: | The FEBS journal 2018-02, Vol.285 (4), p.752-762 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 762 |
---|---|
container_issue | 4 |
container_start_page | 752 |
container_title | The FEBS journal |
container_volume | 285 |
creator | Ma, Chi Zhang, Qianfei Greten, Tim F. |
description | Hepatocellular carcinoma (HCC) is the sixth most frequent neoplasm and the second leading cause of cancer‐related deaths worldwide. Nonalcoholic fatty liver disease (NAFLD), a common disorder in obese people, has been identified as an important risk factor for HCC. Following the increasing prevalence of obesity, it is expected that the contribution of NAFLD to HCC's incidence worldwide will grow. Recently, a number of studies have been published, which help us better understand cellular and molecular mechanisms of how NAFLD promotes hepatocarcinogensis. Inflammatory cytokines, ER stress and circadian dysregulation, which mediate hepatocyte injury and NAFLD progression, have been identified to promote malignant transformation of hepatocytes. Besides these ‘intrinsic’ effects, lipid dysregulation dramatically affects the liver local microenvironment. The reshaped immune environment has also been found to contribute to the NAFLD‐mediated hepatocarcinogenesis. This review explores recent findings of both ‘intrinsic’ effects on hepatocytes and the role of the local environment in NAFLD‐promoted HCC development.
Nonalcoholic fatty liver disease promotes HCC through both direct effects on hepatocytes, and indirect effects on the environment shaping this into a protumor milieu. NAFLD‐associated events such as the increase of inflammatory cytokines alter gene expression profile of hepatocytes and contribute to malignant transformation. NAFLD also changes the population and functions of liver nonparenchymal cells and favors tumor development. |
doi_str_mv | 10.1111/febs.14209 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1934280411</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2007922488</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3939-4076c86ffde9fe3e739520fb03b98efcc060fce0622cbae3d0f0b01033a0aeed3</originalsourceid><addsrcrecordid>eNp9kU1P3DAQhq0KVL566Q-oLHFBlRbGH0nsY0EsrYTg0CJxsxxn3A1K4q2dgPbf18vucuCAL-ORnnmkmZeQrwzOWX4XHut0ziQH_YkcskrymSwLtff2l48H5CilJwBRSK0_kwOuVFFJVRyS6S4MtnNhEbrWUW_HcUW79hkjbdqENiFdxtCHERNd4NKOwWHXTZ2N1Nno2iH0lo6LGKa_izwR0Y3UDg1th22D3ueSaBh286vsOiH73nYJv2zrMXmYX_-5-jm7vb_5dfXjduaEFnomoSqdKr1vUHsUWAldcPA1iFor9M5BCd4hlJy72qJowEMNDISwYBEbcUzONt68xL8J02j6Nq03sAOGKRmmheQKJGMZPX2HPoUp5tskwwEqzblUKlPfN5SLIaWI3ixj29u4MgzMOgyzDsO8hpHhb1vlVPfYvKG762eAbYCXtsPVByozv778vZH-B3XFl20</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2007922488</pqid></control><display><type>article</type><title>Nonalcoholic fatty liver disease promotes hepatocellular carcinoma through direct and indirect effects on hepatocytes</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Wiley Online Library Free Content</source><source>Free Full-Text Journals in Chemistry</source><creator>Ma, Chi ; Zhang, Qianfei ; Greten, Tim F.</creator><creatorcontrib>Ma, Chi ; Zhang, Qianfei ; Greten, Tim F.</creatorcontrib><description>Hepatocellular carcinoma (HCC) is the sixth most frequent neoplasm and the second leading cause of cancer‐related deaths worldwide. Nonalcoholic fatty liver disease (NAFLD), a common disorder in obese people, has been identified as an important risk factor for HCC. Following the increasing prevalence of obesity, it is expected that the contribution of NAFLD to HCC's incidence worldwide will grow. Recently, a number of studies have been published, which help us better understand cellular and molecular mechanisms of how NAFLD promotes hepatocarcinogensis. Inflammatory cytokines, ER stress and circadian dysregulation, which mediate hepatocyte injury and NAFLD progression, have been identified to promote malignant transformation of hepatocytes. Besides these ‘intrinsic’ effects, lipid dysregulation dramatically affects the liver local microenvironment. The reshaped immune environment has also been found to contribute to the NAFLD‐mediated hepatocarcinogenesis. This review explores recent findings of both ‘intrinsic’ effects on hepatocytes and the role of the local environment in NAFLD‐promoted HCC development.
Nonalcoholic fatty liver disease promotes HCC through both direct effects on hepatocytes, and indirect effects on the environment shaping this into a protumor milieu. NAFLD‐associated events such as the increase of inflammatory cytokines alter gene expression profile of hepatocytes and contribute to malignant transformation. NAFLD also changes the population and functions of liver nonparenchymal cells and favors tumor development.</description><identifier>ISSN: 1742-464X</identifier><identifier>EISSN: 1742-4658</identifier><identifier>DOI: 10.1111/febs.14209</identifier><identifier>PMID: 28857485</identifier><language>eng</language><publisher>England: Blackwell Publishing Ltd</publisher><subject>Animals ; Carcinoma, Hepatocellular - immunology ; Carcinoma, Hepatocellular - metabolism ; Carcinoma, Hepatocellular - pathology ; CD4 T cells ; CD8 T cells ; circadian dysregulation ; Circadian rhythms ; Cytokines ; ER stress ; Fatty liver ; gut microbiome ; HCC ; Hepatocellular carcinoma ; Hepatocytes ; Hepatocytes - immunology ; Hepatocytes - metabolism ; Hepatocytes - pathology ; Humans ; Inflammation ; inflammatory cytokine ; Liver ; Liver cancer ; Liver diseases ; Liver Neoplasms - immunology ; Liver Neoplasms - metabolism ; Liver Neoplasms - pathology ; Molecular modelling ; myeloid cells ; NAFLD ; NKT cells ; Non-alcoholic Fatty Liver Disease - immunology ; Non-alcoholic Fatty Liver Disease - metabolism ; Non-alcoholic Fatty Liver Disease - pathology ; Obesity ; Risk Factors ; Tumor Microenvironment - immunology</subject><ispartof>The FEBS journal, 2018-02, Vol.285 (4), p.752-762</ispartof><rights>Published 2017. This article is a U.S. Government work and is in the public domain in the USA.</rights><rights>Copyright © 2018 Federation of European Biochemical Societies</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3939-4076c86ffde9fe3e739520fb03b98efcc060fce0622cbae3d0f0b01033a0aeed3</citedby><cites>FETCH-LOGICAL-c3939-4076c86ffde9fe3e739520fb03b98efcc060fce0622cbae3d0f0b01033a0aeed3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Ffebs.14209$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Ffebs.14209$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,1427,27903,27904,45553,45554,46388,46812</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28857485$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ma, Chi</creatorcontrib><creatorcontrib>Zhang, Qianfei</creatorcontrib><creatorcontrib>Greten, Tim F.</creatorcontrib><title>Nonalcoholic fatty liver disease promotes hepatocellular carcinoma through direct and indirect effects on hepatocytes</title><title>The FEBS journal</title><addtitle>FEBS J</addtitle><description>Hepatocellular carcinoma (HCC) is the sixth most frequent neoplasm and the second leading cause of cancer‐related deaths worldwide. Nonalcoholic fatty liver disease (NAFLD), a common disorder in obese people, has been identified as an important risk factor for HCC. Following the increasing prevalence of obesity, it is expected that the contribution of NAFLD to HCC's incidence worldwide will grow. Recently, a number of studies have been published, which help us better understand cellular and molecular mechanisms of how NAFLD promotes hepatocarcinogensis. Inflammatory cytokines, ER stress and circadian dysregulation, which mediate hepatocyte injury and NAFLD progression, have been identified to promote malignant transformation of hepatocytes. Besides these ‘intrinsic’ effects, lipid dysregulation dramatically affects the liver local microenvironment. The reshaped immune environment has also been found to contribute to the NAFLD‐mediated hepatocarcinogenesis. This review explores recent findings of both ‘intrinsic’ effects on hepatocytes and the role of the local environment in NAFLD‐promoted HCC development.
Nonalcoholic fatty liver disease promotes HCC through both direct effects on hepatocytes, and indirect effects on the environment shaping this into a protumor milieu. NAFLD‐associated events such as the increase of inflammatory cytokines alter gene expression profile of hepatocytes and contribute to malignant transformation. NAFLD also changes the population and functions of liver nonparenchymal cells and favors tumor development.</description><subject>Animals</subject><subject>Carcinoma, Hepatocellular - immunology</subject><subject>Carcinoma, Hepatocellular - metabolism</subject><subject>Carcinoma, Hepatocellular - pathology</subject><subject>CD4 T cells</subject><subject>CD8 T cells</subject><subject>circadian dysregulation</subject><subject>Circadian rhythms</subject><subject>Cytokines</subject><subject>ER stress</subject><subject>Fatty liver</subject><subject>gut microbiome</subject><subject>HCC</subject><subject>Hepatocellular carcinoma</subject><subject>Hepatocytes</subject><subject>Hepatocytes - immunology</subject><subject>Hepatocytes - metabolism</subject><subject>Hepatocytes - pathology</subject><subject>Humans</subject><subject>Inflammation</subject><subject>inflammatory cytokine</subject><subject>Liver</subject><subject>Liver cancer</subject><subject>Liver diseases</subject><subject>Liver Neoplasms - immunology</subject><subject>Liver Neoplasms - metabolism</subject><subject>Liver Neoplasms - pathology</subject><subject>Molecular modelling</subject><subject>myeloid cells</subject><subject>NAFLD</subject><subject>NKT cells</subject><subject>Non-alcoholic Fatty Liver Disease - immunology</subject><subject>Non-alcoholic Fatty Liver Disease - metabolism</subject><subject>Non-alcoholic Fatty Liver Disease - pathology</subject><subject>Obesity</subject><subject>Risk Factors</subject><subject>Tumor Microenvironment - immunology</subject><issn>1742-464X</issn><issn>1742-4658</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU1P3DAQhq0KVL566Q-oLHFBlRbGH0nsY0EsrYTg0CJxsxxn3A1K4q2dgPbf18vucuCAL-ORnnmkmZeQrwzOWX4XHut0ziQH_YkcskrymSwLtff2l48H5CilJwBRSK0_kwOuVFFJVRyS6S4MtnNhEbrWUW_HcUW79hkjbdqENiFdxtCHERNd4NKOwWHXTZ2N1Nno2iH0lo6LGKa_izwR0Y3UDg1th22D3ueSaBh286vsOiH73nYJv2zrMXmYX_-5-jm7vb_5dfXjduaEFnomoSqdKr1vUHsUWAldcPA1iFor9M5BCd4hlJy72qJowEMNDISwYBEbcUzONt68xL8J02j6Nq03sAOGKRmmheQKJGMZPX2HPoUp5tskwwEqzblUKlPfN5SLIaWI3ixj29u4MgzMOgyzDsO8hpHhb1vlVPfYvKG762eAbYCXtsPVByozv778vZH-B3XFl20</recordid><startdate>201802</startdate><enddate>201802</enddate><creator>Ma, Chi</creator><creator>Zhang, Qianfei</creator><creator>Greten, Tim F.</creator><general>Blackwell Publishing Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>7TM</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>201802</creationdate><title>Nonalcoholic fatty liver disease promotes hepatocellular carcinoma through direct and indirect effects on hepatocytes</title><author>Ma, Chi ; Zhang, Qianfei ; Greten, Tim F.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3939-4076c86ffde9fe3e739520fb03b98efcc060fce0622cbae3d0f0b01033a0aeed3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Animals</topic><topic>Carcinoma, Hepatocellular - immunology</topic><topic>Carcinoma, Hepatocellular - metabolism</topic><topic>Carcinoma, Hepatocellular - pathology</topic><topic>CD4 T cells</topic><topic>CD8 T cells</topic><topic>circadian dysregulation</topic><topic>Circadian rhythms</topic><topic>Cytokines</topic><topic>ER stress</topic><topic>Fatty liver</topic><topic>gut microbiome</topic><topic>HCC</topic><topic>Hepatocellular carcinoma</topic><topic>Hepatocytes</topic><topic>Hepatocytes - immunology</topic><topic>Hepatocytes - metabolism</topic><topic>Hepatocytes - pathology</topic><topic>Humans</topic><topic>Inflammation</topic><topic>inflammatory cytokine</topic><topic>Liver</topic><topic>Liver cancer</topic><topic>Liver diseases</topic><topic>Liver Neoplasms - immunology</topic><topic>Liver Neoplasms - metabolism</topic><topic>Liver Neoplasms - pathology</topic><topic>Molecular modelling</topic><topic>myeloid cells</topic><topic>NAFLD</topic><topic>NKT cells</topic><topic>Non-alcoholic Fatty Liver Disease - immunology</topic><topic>Non-alcoholic Fatty Liver Disease - metabolism</topic><topic>Non-alcoholic Fatty Liver Disease - pathology</topic><topic>Obesity</topic><topic>Risk Factors</topic><topic>Tumor Microenvironment - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ma, Chi</creatorcontrib><creatorcontrib>Zhang, Qianfei</creatorcontrib><creatorcontrib>Greten, Tim F.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>The FEBS journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ma, Chi</au><au>Zhang, Qianfei</au><au>Greten, Tim F.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Nonalcoholic fatty liver disease promotes hepatocellular carcinoma through direct and indirect effects on hepatocytes</atitle><jtitle>The FEBS journal</jtitle><addtitle>FEBS J</addtitle><date>2018-02</date><risdate>2018</risdate><volume>285</volume><issue>4</issue><spage>752</spage><epage>762</epage><pages>752-762</pages><issn>1742-464X</issn><eissn>1742-4658</eissn><abstract>Hepatocellular carcinoma (HCC) is the sixth most frequent neoplasm and the second leading cause of cancer‐related deaths worldwide. Nonalcoholic fatty liver disease (NAFLD), a common disorder in obese people, has been identified as an important risk factor for HCC. Following the increasing prevalence of obesity, it is expected that the contribution of NAFLD to HCC's incidence worldwide will grow. Recently, a number of studies have been published, which help us better understand cellular and molecular mechanisms of how NAFLD promotes hepatocarcinogensis. Inflammatory cytokines, ER stress and circadian dysregulation, which mediate hepatocyte injury and NAFLD progression, have been identified to promote malignant transformation of hepatocytes. Besides these ‘intrinsic’ effects, lipid dysregulation dramatically affects the liver local microenvironment. The reshaped immune environment has also been found to contribute to the NAFLD‐mediated hepatocarcinogenesis. This review explores recent findings of both ‘intrinsic’ effects on hepatocytes and the role of the local environment in NAFLD‐promoted HCC development.
Nonalcoholic fatty liver disease promotes HCC through both direct effects on hepatocytes, and indirect effects on the environment shaping this into a protumor milieu. NAFLD‐associated events such as the increase of inflammatory cytokines alter gene expression profile of hepatocytes and contribute to malignant transformation. NAFLD also changes the population and functions of liver nonparenchymal cells and favors tumor development.</abstract><cop>England</cop><pub>Blackwell Publishing Ltd</pub><pmid>28857485</pmid><doi>10.1111/febs.14209</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1742-464X |
ispartof | The FEBS journal, 2018-02, Vol.285 (4), p.752-762 |
issn | 1742-464X 1742-4658 |
language | eng |
recordid | cdi_proquest_miscellaneous_1934280411 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete; Wiley Online Library Free Content; Free Full-Text Journals in Chemistry |
subjects | Animals Carcinoma, Hepatocellular - immunology Carcinoma, Hepatocellular - metabolism Carcinoma, Hepatocellular - pathology CD4 T cells CD8 T cells circadian dysregulation Circadian rhythms Cytokines ER stress Fatty liver gut microbiome HCC Hepatocellular carcinoma Hepatocytes Hepatocytes - immunology Hepatocytes - metabolism Hepatocytes - pathology Humans Inflammation inflammatory cytokine Liver Liver cancer Liver diseases Liver Neoplasms - immunology Liver Neoplasms - metabolism Liver Neoplasms - pathology Molecular modelling myeloid cells NAFLD NKT cells Non-alcoholic Fatty Liver Disease - immunology Non-alcoholic Fatty Liver Disease - metabolism Non-alcoholic Fatty Liver Disease - pathology Obesity Risk Factors Tumor Microenvironment - immunology |
title | Nonalcoholic fatty liver disease promotes hepatocellular carcinoma through direct and indirect effects on hepatocytes |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T21%3A19%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Nonalcoholic%20fatty%20liver%20disease%20promotes%20hepatocellular%20carcinoma%20through%20direct%20and%20indirect%20effects%20on%20hepatocytes&rft.jtitle=The%20FEBS%20journal&rft.au=Ma,%20Chi&rft.date=2018-02&rft.volume=285&rft.issue=4&rft.spage=752&rft.epage=762&rft.pages=752-762&rft.issn=1742-464X&rft.eissn=1742-4658&rft_id=info:doi/10.1111/febs.14209&rft_dat=%3Cproquest_cross%3E2007922488%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2007922488&rft_id=info:pmid/28857485&rfr_iscdi=true |